A first-of-its-kind study tested the safety of psilocybin and found that patients experienced clinically significant ...

CU Anschutz scientists and providers offer a robust community of research and evidence-based care to help lessen the ...

Two small studies published recently in Nature offer early, but important validation that stem cell treatments for Parkinson’s disease are viable.

Parkinson's disease is a common neurological disorder, and April is widely recognized as Parkinson’s Awareness Month. The ...

The results indicate that "now we have the potential to really, really halt this disease in its tracks," says Dr. Mya Schiess ...

A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in ...

William Daggett was diagnosed with Parkinson's disease several years ago. A brain surgery has helped to the quiet the tremors ...

The study is the latest to look for blood biomarkers that could serve as early warning signs of Parkinson’s. View on euronews ...

While a comprehensive cure-all to these neurological conditions is unlikely, scientists are making headway into understanding their fundamental characteristics with the hope of preventing or ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Another quasi-experimental study -- this one using Australian records -- showed that being eligible for a herpes zoster (shingles) vaccine based solely on date of birth lowered the odds of ...

Researchers in the TrPR Program, within UCSF’s Department of Psychiatry and Behavioral Sciences and the Department of Neurology ... a Nature publication. Psilocybin’s lasting mood and motor effects ...